Journals / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 2

Relationship of Serum Copper and Zinc Levels with PlasmaNT-proBNP Level in Men with Ischemic Origin Chronic HeartFailure

Pages
172–179
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: In the high nt-proBNP group, the serum Cu mean level was low compared to the nt-proBNP group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Heart failure (HF) is one of the main causes of cardiovascular mortality and mobidity today.
📊
Key Findings & Data:Despite allthe advances in the diagnosis and treatment of HF, mortality and morbidity rates could not be reduced to the desiredlevels.
💡
Conclusion & Impact:Results: In the high nt-proBNP group, the serum Cu mean level was low compared to the nt-proBNP group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Heart failure (HF) is one of the main causes of cardiovascular mortality and mobidity today. Despite allthe advances in the diagnosis and treatment of HF, mortality and morbidity rates could not be reduced to the desiredlevels. Therefore, it is important to identify new prognostic factors in these patients. Recent studies show that micro nutrient dyshomeostasis may play a role in the pathophysiology of HF. In this study, it was aimed to investigate therelationship between copper (Cu), zinc (Zn) and Cu / Zn ratio and N-terminal pro-B type natriuretic peptide (NT-proBNP)levels in male patients followed with ischemic HF. Methods: 57 male patients who were followed up in the cardiology outpatient clinic with a diagnosis of compensatedchronic HF of ischemic origin were divided into two groups as high and low according to the NT-proBNP level, whoseprognostic limit value was reported as 1000 ng / L. The control group was composed of 24 patients with similar demo graphic characteristics, except for the presence of HF. Results: In the high nt-proBNP group, the serum Cu mean level was low compared to the nt-proBNP group (p

🔖

Cite This Article

ŞAHİN, A. R., AVCI, D., ÇELİK, E., AKSU, E., KILINÇ, M., ONUS, A. E. (2022). Relationship of Serum Copper and Zinc Levels with PlasmaNT-proBNP Level in Men with Ischemic Origin Chronic HeartFailure. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 2, 172–179. https://ajindex.com/articles/508607

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011;8:1308–39
  2. Weber KT, Weglicki WB, Simpson RU. Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res 2009;81:500–8
  3. Shokrzadeh M, Ghaemian A, Salehifar E, Aliakbari S, Saravi SS, Ebrahimi P. Serum zinc and copper levels in ischemic cardiomyopathy. Biol Trace Elem Res 2009;127:116–23
  4. Alexanian I, Parissis J, Farmakis D, Athanaselis S, Pappas L, Gavrielatos G, et al. Clinical and echocardiographic correlates of serum copper and zinc in acute and chronic heart failure. Clin Res Cardiol 2014;103:938–49
  5. Lai MY, Kan WC, Huang YT, Chen J, Shiao CC. The predictivity of N-terminal pro b-type natriuretic peptide for all-cause mortality in various follow-up periods among heart failure patients. J Clin Med 2019;8:357
  6. Wei BQ, Yang YJ, Zhang J, Dou KF, Zhang YH, Huang XH, et al. Predictive value of admission amino-terminal pro-B-type natriuretic peptide on in-hospital mortality in patients with decompensated heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 2009;37:481–5
  7. Chenevier-Gobeaux C, Allo JC, Arthaud M, Achkar R, Claessens YE, Ekindjian OG, et al. N-Terminal pro B-type natriuretic peptide testing for short-term prognosis in breathless older adults. Am J Emerg Med 2008;26:555–60
  8. Lam CSP, Li YH, Bayes-Genis A, Ariyachaipanich A, Huan DQ, Sato N, et al. The role of N-terminal pro-B-type natriuretic peptide in prognostic evaluation of heart failure. J Chin Med Assoc 2019;82:447–51
  9. Huang L, Shen R, Huang L, Yu J, Rong H. Association between serum copper and heart failure: a meta-analysis. Asia Pac J Clin Nutr 2019;28:761–9
  10. Yu X, Huang L, Zhao J, Wang Z, Yao W, Wu X, et al. The relationship between serum zinc level and heart failure: a meta analysis. Biomed Res Int 2018;25;2018:2739014
  11. Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, et al; Heart Failure Association of the European Society of Cardiology (HFA). EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2013;15:808–17
  12. Topuzoglu G, Erbay AR, Karul AB, Y